http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8946190-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24de8e23be1083abd94e7ba2ee4f1ff2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c01190a01a9ea6a747394869a638fdc4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4fc538aabc029bbeb14fa27cae4d5594
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_534bf8414675a4df1f3609910d91563e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2008-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51dbb8377ae0c07d99c7d76177e82010
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40d9e023e37669afa4c0730a441baecb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1ea9e4fb53633f89c0633b433e023ba
publicationDate 2015-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-8946190-B2
titleOfInvention Medium-chain length fatty acids, salts and triglycerides in combination with gemcitabine for treatment of pancreatic cancer
abstract The present invention relates to the use of medium-chain length fatty acids of formula I, triglycerides of formula 2 (wherein n=6-10), salts thereof, or mixtures thereof, in combination with gemcitabine and optionally erlotinib in the treatment of pancreatic cancer in human patients. Exemplary medium-chain length fatty acid/triglyceride compounds include capric acid, sodium caprate, tricaprin, lauric acid, sodium laurate, and trilaurin.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11351139-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016206585-A1
priorityDate 2007-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006128800-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004069237-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003049302-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02083120-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129492452
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226443530
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10850
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68294
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226496815
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397462
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411984
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127639621
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127368706
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16186314
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123631
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395065
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396322
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413898
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13711
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10851
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127956138
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396379
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19772918
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3893
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399616
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2735067
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7427
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID379
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128459704
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127452498
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID162213164
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176870
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128390838
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454658092
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399858
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID311231738
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4457968
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87061374
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226454171
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396684
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6335613
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID117848246
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395791
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396020
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226432977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60749
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69310

Total number of triples: 86.